Reform Of MHRA & Clinical Trials Needed To Unlock UK’s ‘Medical & Scientific Potential’
Executive Summary
Moderna says that if the right investments are made in reforming the Medicines and Healthcare products Regulatory Agency, the National Health Service and other public health bodies, the UK will be in a strong position to mitigate “future shocks” in the health care system.